Posters | World Medical Innovation Forum - Gene and Cell Therapy

2021 Posters

Inspiring GCT Innovation

Nearly 50 gene and cell therapy technologies profiled by Harvard Medical School inventors and clinicians who will bring technologies to patients as presented during the 2021 World Medical Innovation Forum.

2021 Posters

Cell Based Therapies for Regeneration of Ovarian Function: Biomimetic Hormones for Replacement after Ovarian Failure
Raymond Anchan, MD, PhD
Reproductive Endocrinology & Infertility Specialist, Associate Gynecologist, BWH; Assistant Professor, HMS
Macrophage Cell Therapy in Asthma
Barbara Balestrieri, MD

Assosciate Innumologist, BWH; Assistant Professo, HMS

Retinal ganglion cell replacement for Glaucoma: improving functional integration through slow-release growth factor system
Petr Baranov, MD, PhD

Assistant Scientist, Mass Eye and Ear; Assistant Professor, HMS

A Translatable Blood-Brain-Barrier-Penetrant AAV Gene Therapy Vector
Fengfeng Bei, PhD
Principal Investigator, Neurosurgery, BWH; Assistant Professor, HMS
Chimeric Antigen Ligand (CAL) T Cell Therapy for Autoimmune Disorders
Curtis Cetrulo, MD
Director, Laboratory for Cellular Immunotherapy, MGH; Associate Professor, HMS
Therapeutic potential of Antigen Specific T Regulatory cell enriched Lines (ASTRL) from Kidney Transplant Patients
Anil Chandraker, MD
Medical Director of Kidney and Pancreas Transplantation, BWH; Associate Professor, HMS
Targeting Histone Deacetylase 11 to Stimulate Optic Nerve Growth and Regeneration
DongFeng Chen, MD, PhD
Associate Scientist, Ophthalmology, Schepens Eye Research Institute, MEE; Associate Professor, HMSS
Gene Therapy to Treat Human Recessive Deafness (DFNB8/10) Caused by a TMPRSS3 Mutatio
Zheng-Yi Chen, PhD
Associate Scientist, Eaton-Peabody Laboratories, MEE; Associate Professor, HMS
Editing Stem Cells for Recurrent Hematological Malignancies Treatment
Bin Kuan Chou, PhD

Postdoctoral Fellow, Surgery, MGH

Development of Mini-Gene Therapy for Usher Syndrome Type 1F
Pedro De la Torre Marquez, PhD

Postdoctoral Researcher, Otolaryngology, Mass Eye and Ear

CNS-Targeted Gene Therapy for an Ultra-Rare Disease
Yulia Grishchuck, PhD
Center for Human Genetic Research, MGH; Assistant Professor, HMS
YJLeukin: A Novel Potent Chimeric IL2 in Cleavable or Free Form For Cancer Immunotherapy
Youssef Jounaidi, PhD
Instructor, Anaesthesia, MGH; Instructor, HMS
Development and Application of Novel CRISPR-Cas Base Editors to Model and Treat Human Diseases
Benjamin Kleinstiver, PhD
Investigator, Pathology, MGH; Assistant Professor, HMS
Development of RNA – Targeting Therapies for Malignant Brain Tumors
Anna Krichevsky, PhD
Scientist, Center for Neurologic Diseases, Neurology, BWH; Associate Professor, HMS
Optogenetic Stimulation of the Cochlear Nucleus: Implications for New Generation Auditory Implants Based on Light
Daniel Lee, MD
Director, Pediatric Otology and Neurotology, MEE; Associate Professor, HMS
CRISPR/Cas9-based genome editing approaches for RP1 associated autosomal dominant Retinitis Pigmentosa
Qin Liu, MD, PhD
Assistant Professor, Ophthalmology, MEE, HMS
Computational Technology Platform to Identify RNA-Therapeutics Targets
Guia Guffanti Masetti, PhD
Associate Neuroscientist, Neurobiology of Fear Laboratory, McLean; Assistant Professor, HMS
Targeting the Long Non-Coding RNA INCR1 to Improve Cancer Immunotherapy
Marco Mineo, PhD
Instructor in Neurosurgery, BWH
Population and Patient-Specific Off-Target Site Analysis for CRISPR Genome Editing
Luca Pinello, PhD
Associate Pathologist, MGH; Associate Professor, HMS
Novel Allogeneic B Cell Immune Therapy for Amyotrophic Lateral Sclerosis
Mark Poznansky, MD, PhD
Director, Vaccine and Immunotherapy Center, MGH; Associate Professor, HMS
Human iPSC Derived Brown Adipocyte as a Treatment for Obesity
Jyoti Rao, PhD
Postdoctoral Fellow, Pathology, BWH
Discovery of Novel Therapeutics to Treat Autoimmune Disease Through Targeting Follicular Regulatory T Cells
Peter Sage, PhD
Associate Immunologist, BWH; Associate Professor, HMS
Synthetic mRNA Nanomedicine: An Emerging Therapy for Cancer and Genetic Diseases?
Jinjun Shi, PhD
Faculty Member, Center for Nanomedicine, BWH; Associate Professor, HMS
Improving Cell Therapy Manufacturing with High Performance Inertial Microfluidics
Kyle Smith, PhD
CTO, BendBio
Olfactory Ensheathing Glia for Cancer Gene/Cell ImmunoTherapy
Bakhos Tannous, PhD
Associate Neuroscientist, Neurology, MGH; Associate Professor, HMS
Develop First-In-Class Therapeutics for Vision Loss Due to Neurodegeneration and Enhance Efficacy of Cell Transplants and Gene Therapy
Demetrios Vavvas, MD, PhD
Monte J. Wallace Ophthalmology Chair in Retina, MEE; Associate Professor, HMS
Prevention and Treatment of GvHD in Humans with B7-H3 CAR T Cells-An Unexpected Finding
Xinhui Wang, MD, PhD
Associate Immunologist, MGH; Assistant Professor, HMS
Preserving and Restoring Vision with Allogenic Cone Progenitor Cells
Michael Young, PhD
Director, Minda de Gunzburg Center for Retinal Regeneration, MEE; Associate Professor, HMS